MANE: the cash flow

MyFinsight

For the quarter ending 2026-03-31, MANE had $146,646K increase in cash & cash equivalents over the period. -$21,168K in free cash flow.

Cash Flow	2026-03-31	2025-12-31
Net loss	-27,232	-69,995
Stock-based compensation	5,259	1,440
Research and development expenses paid with convertible and promissory notes	-	0
Non-cash research and development services	621	1,999
Net accretion of discount/premium on debt securities	73	556
Accrued interest earned	-	647
Other	-6	-43
Prepaid expenses and other current assets	-4,360	8,235
Interest receivable on marketable securities	1,499	-
Accounts payable	-1,055	-122
Accrued expenses	-1,373	4,510
Other long term assets	174	-
Other current liabilities and lease liabilities	-8	-39
Net cash used in operating activities	-21,168	-71,602
Purchase of property, plant and equipment	0	24
Purchases of marketable securities	122,988	143,852
Maturities of marketable securities	21,689	25,018
Net cash used in investing activities	-101,299	-118,858
Issuance of convertible notes	-	0
Issuance of preferred stock-Series BPreferred Stock	-	8,433
Issuance of preferred stock-Series CPreferred Stock	-	151,000
Payment of promissory note	-	0
Issuance of preferred stock	0	-
Preferred stock issuance costs	-	447
Initial public offering, net of issuance costs paid	269,102	-
Exercise of stock options	11	156
Net cash provided by financing activities	269,113	159,142
Net increase (decrease) in cash and cash equivalents	146,646	-31,318
Cash and cash equivalentsbeginning of period	21,766	53,084
Cash and cash equivalentsend of period	168,412	21,766

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.